Caribou Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Caribou Biosciences, Inc. (CRBU) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-05
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-06-30 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-09-30 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-06-30 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Caribou Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-05 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-12 | 0.00% 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-05 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-06 | 0.00% 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-12 | 0.00% 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-10 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-06 | 0.00% 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-06 | 0.00% 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-11 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-07 | 0.00% 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-08 | 0.00% 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-09 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-08 | 0.00% 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-09 | 0.00% 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-21 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2021-09-02 | 0.00% 10-Q · filed 2021-09-02 | ||
| 2019-12-31 | 0.00% 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |